š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
Thrive Health - Beverly Hills
Start Date
2024-03-27
Trial ID
NCT06307613
Treatments Being Tested
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blinded, placebo-con...
Status
Completed
Location
Investigator site 77 - US0010086
Start Date
2020-12-01
Trial ID
NCT04598451
Treatments Being Tested
This study's purpose is to measure the treatment response from efgartigimod...
Status
Completed
Location
Neuromuscular Research Center
Start Date
2022-10-12
Trial ID
NCT05523167
Treatments Being Tested
The main purpose of this study is to evaluate the effect and safety of efga...
Status
Recruiting
Location
Arizona Arthritis and Rheumatology Associates
Start Date
2024-11-11
Trial ID
NCT06655155
Treatments Being Tested
ARGX-113-2009 is an operationally seamless 2-part, phase 2/3, prospective, ...
Status
Completed
Location
Investigator site 74 - US0010178
Start Date
2022-06-09
Trial ID
NCT05267600
Treatments Being Tested
This study aims to assess the efficacy and safety of efgartigimod PH20 in a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-14
Trial ID
NCT07760818
Treatments Being Tested
The main purpose of this study is to look at how efgartigimod affects thyro...
Status
Recruiting
Location
Diabetes Associates Medical Group
Start Date
2026-06-10
Trial ID
NCT07570316
Treatments Being Tested
This is a Phase 2 study to evaluate the safety and efficacy of the subcutan...
Status
Completed
Location
Investigator site 0010065
Start Date
2020-04-15
Trial ID
NCT04281472
Treatments Being Tested
This is a phase 3, multicenter, randomized, double-blinded, placebo-control...
Status
Completed
Location
Investigator Site 0010116
Start Date
2020-12-16
Trial ID
NCT04687072
Treatments Being Tested